| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.759 | 0.022 | 0.759 | Apoptosis agonist | 0.727 0.026 DBMET02091 0.709 0.029 DBMET02092 0.696 0.031 DBMET02093 | ||
| 0.543 | 0.071 | 0.844 | Antiinflammatory | 0.615 0.049 DBMET02091 0.598 0.054 DBMET02092 0.844 0.01 DBMET02093 | DBMET02093 | |
| 0.448 | 0.007 | 0.448 | Lipid peroxidase inhibitor | 0.42 0.009 DBMET02091 0.396 0.01 DBMET02092 0.413 0.009 DBMET02093 | ||
| 0.391 | 0.036 | 0.422 | Antioxidant | 0.422 0.031 DBMET02091 0.402 0.035 DBMET02092 0.382 0.038 DBMET02093 | DBMET02091 | |
| 0.321 | 0.005 | 0.321 | Aromatase inhibitor | 0.314 0.005 DBMET02091 0.201 0.008 DBMET02092 0.155 0.012 DBMET02093 | ||
| 0.332 | 0.016 | 0.475 | Lipocortins synthesis antagonist | 0.311 0.019 DBMET02091 0.379 0.01 DBMET02092 0.475 0.004 DBMET02093 | DBMET02093 | |
| 0.36 | 0.051 | 0.489 | Apoptosis antagonist | 0.428 0.031 DBMET02091 0.4 0.038 DBMET02092 0.489 0.022 DBMET02093 | DBMET02093 | |
| 0.346 | 0.042 | 0.431 | Sodium/bile acid cotransporter inhibitor | 0.351 0.039 DBMET02091 0.387 0.021 DBMET02092 0.431 0.01 DBMET02093 | DBMET02093 | |
| 0.296 | 0.022 | 0.347 | Melanin inhibitor | 0.278 0.025 DBMET02091 0.278 0.025 DBMET02092 0.347 0.016 DBMET02093 | DBMET02093 | |
| 0.282 | 0.023 | 0.381 | Interferon gamma antagonist | 0.276 0.024 DBMET02091 0.326 0.016 DBMET02092 0.381 0.012 DBMET02093 | DBMET02093 | |
| 0.249 | 0.006 | 0.249 | Estrogen agonist | 0.224 0.007 DBMET02091 0.186 0.009 DBMET02092 0.136 0.012 DBMET02093 | ||
| 0.313 | 0.073 | 0.363 | Caspase 3 stimulant | 0.363 0.055 DBMET02091 0.282 0.088 DBMET02092 0.343 0.061 DBMET02093 | DBMET02091 | |
| 0.239 | 0.01 | 0.239 | Acetylcholine nicotinic antagonist | 0.218 0.011 DBMET02091 0.166 0.017 DBMET02092 0.079 0.056 DBMET02093 | ||
| 0.364 | 0.136 | 0.364 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.329 0.175 DBMET02092 | ||
| 0.276 | 0.051 | 0.551 | Antimitotic | 0.176 0.099 DBMET02091 0.202 0.082 DBMET02092 0.551 0.009 DBMET02093 | DBMET02093 | |
| 0.313 | 0.088 | 0.603 | Transcription factor NF kappa B inhibitor | 0.38 0.068 DBMET02091 0.381 0.068 DBMET02092 0.603 0.031 DBMET02093 | DBMET02093 | |
| 0.266 | 0.045 | 0.34 | Sigma receptor agonist | 0.122 0.111 DBMET02091 0.34 0.032 DBMET02092 0.202 0.061 DBMET02093 | DBMET02092 | |
| 0.265 | 0.048 | 0.511 | Nitric oxide antagonist | 0.301 0.04 DBMET02091 0.266 0.047 DBMET02092 0.511 0.015 DBMET02093 | DBMET02093 | |
| 0.229 | 0.012 | 0.257 | Arachidonic acid antagonist | 0.223 0.015 DBMET02091 0.238 0.009 DBMET02092 0.257 0.004 DBMET02093 | DBMET02093 | |
| 0.205 | 0.003 | 0.205 | CXC chemokine 3 receptor antagonist | 0.141 0.004 DBMET02091 0.155 0.004 DBMET02092 | ||
| 0.222 | 0.027 | 0.222 | Acetylcholinesterase inhibitor | 0.157 0.051 DBMET02091 0.129 0.07 DBMET02092 | ||
| 0.206 | 0.011 | 0.224 | Adenylate cyclase stimulant | 0.224 0.006 DBMET02091 0.19 0.019 DBMET02092 0.223 0.006 DBMET02093 | DBMET02091 | |
| 0.254 | 0.067 | 0.294 | Free radical scavenger | 0.27 0.061 DBMET02091 0.294 0.053 DBMET02092 0.284 0.056 DBMET02093 | DBMET02092 | |
| 0.197 | 0.02 | 0.261 | Microtubule formation inhibitor | 0.191 0.022 DBMET02091 0.21 0.018 DBMET02092 0.261 0.006 DBMET02093 | DBMET02093 | |
| 0.333 | 0.16 | 0.415 | Caspase 9 stimulant | 0.415 0.102 DBMET02091 0.263 0.237 DBMET02092 0.283 0.213 DBMET02093 | DBMET02091 | |
| 0.211 | 0.038 | 0.308 | Protein kinase stimulant | 0.308 0.016 DBMET02091 0.223 0.034 DBMET02092 0.276 0.02 DBMET02093 | DBMET02091 | |
| 0.226 | 0.054 | 0.252 | Neurotrophic factor enhancer | 0.252 0.038 DBMET02091 0.166 0.115 DBMET02092 | DBMET02091 | |
| 0.242 | 0.074 | 0.311 | Angiogenesis stimulant | 0.311 0.045 DBMET02091 0.289 0.054 DBMET02092 0.253 0.069 DBMET02093 | DBMET02091 | |
| 0.21 | 0.042 | 0.21 | Cholinergic | 0.138 0.087 DBMET02091 | ||
| 0.28 | 0.113 | 0.28 | Calcium channel activator | 0.269 0.125 DBMET02091 0.256 0.14 DBMET02092 0.23 0.172 DBMET02093 | ||
| 0.247 | 0.084 | 0.306 | 5 Hydroxytryptamine uptake stimulant | 0.225 0.109 DBMET02091 0.306 0.042 DBMET02092 0.27 0.064 DBMET02093 | DBMET02092 | |
| 0.191 | 0.031 | 0.239 | DNA polymerase I inhibitor | 0.211 0.025 DBMET02091 0.239 0.019 DBMET02092 0.228 0.021 DBMET02093 | DBMET02092 | |
| 0.196 | 0.038 | 0.196 | Tubulin antagonist | 0.13 0.071 DBMET02091 0.129 0.072 DBMET02092 0.108 0.093 DBMET02093 | ||
| 0.247 | 0.09 | 0.248 | 5 Hydroxytryptamine release stimulant | 0.248 0.09 DBMET02091 0.165 0.16 DBMET02092 | DBMET02091 | |
| 0.161 | 0.007 | 0.161 | Cannabinoid CB2 receptor antagonist | 0.109 0.013 DBMET02091 0.05 0.037 DBMET02092 | ||
| 0.15 | 0.006 | 0.15 | Oxytocin antagonist | 0.074 0.013 DBMET02091 0.068 0.014 DBMET02092 | ||
| 0.142 | 0.005 | 0.142 | Aldosterone antagonist | 0.064 0.017 DBMET02091 0.109 0.008 DBMET02092 0.103 0.008 DBMET02093 | ||
| 0.159 | 0.025 | 0.159 | TRPA1 agonist | 0.159 0.025 DBMET02092 0.105 0.079 DBMET02093 | ||
| 0.155 | 0.021 | 0.155 | Androgen antagonist | 0.144 0.024 DBMET02091 0.115 0.036 DBMET02092 0.128 0.029 DBMET02093 | ||
| 0.149 | 0.018 | 0.176 | Anabolic | 0.154 0.016 DBMET02091 0.161 0.013 DBMET02092 0.176 0.008 DBMET02093 | DBMET02093 | |
| 0.162 | 0.04 | 0.183 | Farnesoid X receptor antagonist | 0.155 0.047 DBMET02091 0.176 0.031 DBMET02092 0.183 0.028 DBMET02093 | DBMET02093 | |
| 0.275 | 0.155 | 0.463 | Antibacterial | 0.326 0.117 DBMET02091 0.428 0.065 DBMET02092 0.463 0.052 DBMET02093 | DBMET02093 | |
| 0.212 | 0.099 | 0.492 | Aldehyde oxidase inhibitor | 0.18 0.116 DBMET02091 0.492 0.034 DBMET02092 0.29 0.069 DBMET02093 | DBMET02092 | |
| 0.16 | 0.054 | 0.171 | Histone deacetylase SIRT1 inhibitor | 0.171 0.045 DBMET02091 0.155 0.057 DBMET02092 0.152 0.06 DBMET02093 | DBMET02091 | |
| 0.123 | 0.017 | 0.123 | Neuronal nicotinic receptor antagonist | 0.113 0.019 DBMET02091 0.083 0.034 DBMET02092 | ||
| 0.149 | 0.049 | 0.167 | Heat shock protein 70 antagonist | 0.144 0.063 DBMET02091 0.167 0.02 DBMET02092 0.158 0.03 DBMET02093 | DBMET02092 | |
| 0.109 | 0.009 | 0.109 | Estradiol 17 beta-dehydrogenase inhibitor | 0.108 0.009 DBMET02091 0.09 0.012 DBMET02092 0.047 0.026 DBMET02093 | ||
| 0.117 | 0.018 | 0.129 | Na+ K+ transporting ATPase inhibitor | 0.129 0.012 DBMET02091 0.113 0.021 DBMET02092 0.124 0.014 DBMET02093 | DBMET02091 | |
| 0.116 | 0.018 | 0.116 | CXC chemokine receptor antagonist | 0.079 0.038 DBMET02091 0.082 0.035 DBMET02092 | ||
| 0.234 | 0.137 | 0.484 | Cholesterol antagonist | 0.391 0.051 DBMET02091 0.462 0.039 DBMET02092 0.484 0.035 DBMET02093 | DBMET02093 | |
| 0.178 | 0.082 | 0.289 | Hepatoprotectant | 0.235 0.048 DBMET02091 0.222 0.053 DBMET02092 0.289 0.033 DBMET02093 | DBMET02093 | |
| 0.1 | 0.007 | 0.1 | Heme oxygenase stimulant | 0.086 0.012 DBMET02091 0.095 0.008 DBMET02092 0.074 0.021 DBMET02093 | ||
| 0.108 | 0.016 | 0.108 | Estrogen-related receptor beta agonist | 0.094 0.034 DBMET02091 0.094 0.034 DBMET02092 0.083 0.059 DBMET02093 | ||
| 0.216 | 0.124 | 0.236 | Gastrin inhibitor | 0.236 0.097 DBMET02092 0.211 0.132 DBMET02093 | DBMET02092 | |
| 0.138 | 0.047 | 0.138 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.094 DBMET02091 0.119 0.084 DBMET02092 0.125 0.069 DBMET02093 | ||
| 0.146 | 0.055 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.139 0.076 DBMET02091 0.165 0.017 DBMET02092 0.176 0.009 DBMET02093 | DBMET02093 | |
| 0.096 | 0.006 | 0.096 | Vasopressin 2 antagonist | 0.059 0.011 DBMET02091 0.052 0.013 DBMET02092 | ||
| 0.091 | 0.005 | 0.091 | Vasopressin 1B antagonist | 0.043 0.009 DBMET02091 0.04 0.01 DBMET02092 | ||
| 0.096 | 0.016 | 0.105 | Androgen agonist | 0.097 0.016 DBMET02091 0.083 0.022 DBMET02092 0.105 0.013 DBMET02093 | DBMET02093 | |
| 0.084 | 0.007 | 0.084 | Vasopressin 1A antagonist | 0.044 0.014 DBMET02091 0.028 0.021 DBMET02092 | ||
| 0.103 | 0.026 | 0.112 | CDC25A inhibitor | 0.108 0.024 DBMET02091 0.112 0.022 DBMET02092 0.092 0.032 DBMET02093 | DBMET02092 | |
| 0.203 | 0.129 | 0.233 | Transcription factor STAT3 inhibitor | 0.185 0.156 DBMET02091 0.225 0.106 DBMET02092 0.233 0.098 DBMET02093 | DBMET02093 | |
| 0.103 | 0.03 | 0.121 | Glycine receptor antagonist | 0.089 0.044 DBMET02091 0.106 0.028 DBMET02092 0.121 0.018 DBMET02093 | DBMET02093 | |
| 0.129 | 0.058 | 0.245 | Cholesterol synthesis inhibitor | 0.121 0.064 DBMET02091 0.19 0.029 DBMET02092 0.245 0.018 DBMET02093 | DBMET02093 | |
| 0.082 | 0.012 | 0.185 | 5-Alpha-reductase inhibitor | 0.077 0.013 DBMET02091 0.185 0.005 DBMET02092 0.164 0.006 DBMET02093 | DBMET02092 | |
| 0.078 | 0.011 | 0.078 | Vasopressin 1 antagonist | 0.029 0.025 DBMET02091 | ||
| 0.076 | 0.009 | 0.076 | Adenylate cyclase 1 inhibitor | |||
| 0.07 | 0.006 | 0.07 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.063 0.008 DBMET02091 0.051 0.011 DBMET02092 | ||
| 0.135 | 0.072 | 0.23 | Amylase inhibitor | 0.23 0.034 DBMET02091 0.146 0.066 DBMET02092 0.156 0.061 DBMET02093 | DBMET02091 | |
| 0.139 | 0.077 | 0.139 | Pregnane X receptor agonist | |||
| 0.165 | 0.104 | 0.165 | Psychostimulant | 0.152 0.114 DBMET02091 | ||
| 0.07 | 0.01 | 0.129 | Retinoid X receptor agonist | 0.071 0.01 DBMET02091 0.129 0.003 DBMET02092 0.078 0.008 DBMET02093 | DBMET02092 | |
| 0.067 | 0.008 | 0.067 | Parathyroid hormone antagonist | 0.059 0.012 DBMET02091 0.049 0.023 DBMET02092 | ||
| 0.076 | 0.017 | 0.076 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.05 0.03 DBMET02091 0.051 0.029 DBMET02092 0.046 0.034 DBMET02093 | ||
| 0.062 | 0.006 | 0.062 | Glucose-6-phosphate dehydrogenase inhibitor | 0.051 0.011 DBMET02091 0.054 0.009 DBMET02092 0.046 0.014 DBMET02093 | ||
| 0.07 | 0.014 | 0.076 | Pregnane X receptor antagonist | 0.076 0.009 DBMET02092 0.065 0.022 DBMET02093 | DBMET02092 | |
| 0.064 | 0.009 | 0.108 | GABA uptake inhibitor | 0.072 0.006 DBMET02091 0.108 0.003 DBMET02092 0.058 0.011 DBMET02093 | DBMET02092 | |
| 0.127 | 0.072 | 0.133 | Vanilloid 1 agonist | 0.133 0.06 DBMET02091 | DBMET02091 | |
| 0.063 | 0.008 | 0.063 | Potassium channel Kv1.1 blocker | |||
| 0.058 | 0.005 | 0.058 | Tubulin agonist | 0.049 0.008 DBMET02091 0.051 0.008 DBMET02092 0.054 0.007 DBMET02093 | ||
| 0.072 | 0.02 | 0.11 | Lipocortins synthesis agonist | 0.07 0.021 DBMET02091 0.073 0.018 DBMET02092 0.11 0.004 DBMET02093 | DBMET02093 | |
| 0.058 | 0.007 | 0.147 | 5-Alpha-reductase 1 inhibitor | 0.029 0.009 DBMET02091 0.147 0.004 DBMET02092 0.048 0.007 DBMET02093 | DBMET02092 | |
| 0.085 | 0.033 | 0.113 | Glycine receptor agonist | 0.078 0.041 DBMET02091 0.113 0.015 DBMET02092 0.105 0.018 DBMET02093 | DBMET02092 | |
| 0.061 | 0.011 | 0.061 | RNA-directed RNA polymerase stimulant | 0.05 0.013 DBMET02091 0.053 0.012 DBMET02092 0.042 0.016 DBMET02093 | ||
| 0.1 | 0.05 | 0.143 | ABCA1 expression enhancer | 0.099 0.052 DBMET02091 0.143 0.019 DBMET02092 0.134 0.023 DBMET02093 | DBMET02092 | |
| 0.069 | 0.022 | 0.076 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.064 0.026 DBMET02091 0.076 0.018 DBMET02092 0.048 0.047 DBMET02093 | DBMET02092 | |
| 0.052 | 0.007 | 0.175 | 5-Alpha-reductase 2 inhibitor | 0.03 0.009 DBMET02091 0.175 0.003 DBMET02092 0.08 0.006 DBMET02093 | DBMET02092 | |
| 0.053 | 0.008 | 0.065 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.036 0.013 DBMET02091 0.065 0.006 DBMET02092 0.063 0.007 DBMET02093 | DBMET02092 | |
| 0.06 | 0.019 | 0.06 | Antidiuretic hormone antagonist | |||
| 0.053 | 0.013 | 0.135 | Farnesoid X receptor agonist | 0.07 0.007 DBMET02091 0.113 0.004 DBMET02092 0.135 0.003 DBMET02093 | DBMET02093 | |
| 0.083 | 0.044 | 0.22 | Keratolytic | 0.127 0.019 DBMET02091 0.22 0.007 DBMET02092 0.168 0.012 DBMET02093 | DBMET02092 | |
| 0.086 | 0.048 | 0.091 | Thioredoxin reductase inhibitor | 0.091 0.039 DBMET02091 0.083 0.054 DBMET02092 0.079 0.064 DBMET02093 | DBMET02091 | |
| 0.058 | 0.022 | 0.058 | Mineralocorticoid receptor antagonist | 0.044 0.039 DBMET02091 0.055 0.024 DBMET02092 0.05 0.03 DBMET02093 | ||
| 0.049 | 0.014 | 0.075 | Retinoid X receptor antagonist | 0.045 0.017 DBMET02091 0.075 0.003 DBMET02092 0.05 0.012 DBMET02093 | DBMET02092 | |
| 0.087 | 0.052 | 0.1 | 3C-Like protease (SARS coronavirus) inhibitor | 0.084 0.058 DBMET02091 0.1 0.033 DBMET02092 0.082 0.063 DBMET02093 | DBMET02092 | |
| 0.059 | 0.027 | 0.059 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.042 | 0.013 | 0.065 | Retinoid X alpha receptor antagonist | 0.038 0.017 DBMET02091 0.065 0.003 DBMET02092 0.043 0.011 DBMET02093 | DBMET02092 | |
| 0.111 | 0.082 | 0.117 | Cholinergic antagonist | 0.117 0.076 DBMET02091 | DBMET02091 | |
| 0.109 | 0.081 | 0.115 | Acetylcholine antagonist | 0.115 0.075 DBMET02091 | DBMET02091 | |
| 0.141 | 0.117 | 0.153 | 3C-like protease (Human coronavirus) inhibitor | 0.153 0.096 DBMET02092 | DBMET02092 | |
| 0.071 | 0.048 | 0.071 | Cannabinoid receptor antagonist | |||
| 0.033 | 0.01 | 0.033 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.03 0.012 DBMET02091 | ||
| 0.077 | 0.054 | 0.077 | Estrogen receptor alpha antagonist | 0.071 0.066 DBMET02091 0.076 0.056 DBMET02093 | ||
| 0.05 | 0.028 | 0.09 | Microtubule stabilization | 0.048 0.031 DBMET02091 0.054 0.023 DBMET02092 0.09 0.004 DBMET02093 | DBMET02093 | |
| 0.123 | 0.102 | 0.137 | CC chemokine 6 receptor antagonist | 0.136 0.05 DBMET02092 0.137 0.048 DBMET02093 | DBMET02093 | |
| 0.041 | 0.022 | 0.041 | Progesterone antagonist | |||
| 0.083 | 0.064 | 0.125 | Transcription factor NF kappa B stimulant | 0.125 0.023 DBMET02091 0.102 0.037 DBMET02092 0.125 0.023 DBMET02093 | DBMET02093 | |
| 0.037 | 0.02 | 0.066 | Glucocorticoid antagonist | 0.066 0.009 DBMET02093 | DBMET02093 | |
| 0.026 | 0.01 | 0.026 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.062 | 0.047 | 0.087 | CDC25B inhibitor | 0.074 0.034 DBMET02091 0.087 0.022 DBMET02092 0.074 0.033 DBMET02093 | DBMET02092 | |
| 0.085 | 0.071 | 0.152 | HIV-1 integrase (Overall Integration) inhibitor | 0.152 0.025 DBMET02091 0.111 0.046 DBMET02092 0.082 0.075 DBMET02093 | DBMET02091 | |
| 0.246 | 0.234 | 0.338 | 5 Hydroxytryptamine release inhibitor | 0.338 0.126 DBMET02092 0.306 0.158 DBMET02093 | DBMET02092 | |
| 0.15 | 0.139 | 0.15 | Histone acetyltransferase inhibitor | |||
| 0.014 | 0.004 | 0.014 | Progesterone receptor A antagonist | |||
| 0.018 | 0.01 | 0.026 | Telomerase stimulant | 0.023 0.005 DBMET02091 0.018 0.01 DBMET02092 0.026 0.004 DBMET02093 | DBMET02093 | |
| 0.013 | 0.006 | 0.013 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.01 DBMET02092 | ||
| 0.019 | 0.012 | 0.019 | Progesterone agonist | |||
| 0.167 | 0.16 | 0.172 | RNA-directed DNA polymerase inhibitor | 0.172 0.149 DBMET02091 | DBMET02091 | |
| 0.087 | 0.081 | 0.108 | Bile acid receptor antagonist | 0.086 0.084 DBMET02091 0.108 0.035 DBMET02092 0.108 0.034 DBMET02093 | DBMET02093 | |
| 0.034 | 0.031 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.092 | 0.091 | 0.092 | Anesthetic local | |||
| 0.019 | 0.018 | 0.038 | Corticosteroid-like | 0.019 0.018 DBMET02092 0.038 0.004 DBMET02093 | DBMET02093 | |
| 0.03 | 0.03 | 0.094 | Retinoid X alpha receptor agonist | 0.032 0.027 DBMET02091 0.094 0.005 DBMET02092 0.033 0.026 DBMET02093 | DBMET02092 | |
| 0.019 | 0.019 | 0.031 | Retinoid X beta receptor antagonist | 0.031 0.004 DBMET02092 | DBMET02092 | |
| 0.133 | 0.133 | 0.16 | Anesthetic general | 0.16 0.104 DBMET02092 0.155 0.108 DBMET02093 | DBMET02092 | |
| 0.018 | 0.018 | 0.051 | Retinoic acid alpha receptor antagonist | 0.051 0.004 DBMET02092 0.034 0.005 DBMET02093 | DBMET02092 | |
| 0.082 | 0.083 | 0.104 | Glutamate release inhibitor | 0.104 0.037 DBMET02091 | DBMET02091 | |
| 0.137 | 0.139 | 0.219 | Succinate dehydrogenase inhibitor | 0.219 0.036 DBMET02092 0.185 0.062 DBMET02093 | DBMET02092 | |
| 0.073 | 0.078 | 0.116 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.076 0.072 DBMET02091 0.116 0.027 DBMET02092 0.096 0.042 DBMET02093 | DBMET02092 | |
| 0.14 | 0.147 | 0.219 | Insulin sensitizer | 0.179 0.097 DBMET02091 0.202 0.072 DBMET02092 0.219 0.055 DBMET02093 | DBMET02093 | |
| 0.035 | 0.042 | 0.042 | Guanylate cyclase inhibitor | 0.042 0.031 DBMET02091 | DBMET02091 | |
| 0.019 | 0.026 | 0.02 | Vitamin D receptor antagonist | 0.02 0.019 DBMET02091 | DBMET02091 | |
| 0.098 | 0.105 | 0.105 | Estrogen antagonist | 0.105 0.086 DBMET02093 | DBMET02093 | |
| 0.017 | 0.027 | 0.067 | Retinoid X gamma receptor agonist | 0.067 0.004 DBMET02092 0.033 0.009 DBMET02093 | DBMET02092 | |
| 0.045 | 0.056 | 0.121 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 DBMET02091 0.093 0.025 DBMET02092 0.121 0.016 DBMET02093 | DBMET02093 | |
| 0.023 | 0.034 | 0.037 | Retinoid X gamma receptor antagonist | 0.037 0.006 DBMET02092 0.03 0.012 DBMET02093 | DBMET02092 | |
| 0.007 | 0.018 | 0.05 | Glucocorticoid agonist | 0.05 0.004 DBMET02093 | DBMET02093 | |
| 0.05 | 0.062 | 0.107 | HIV-1 integrase (3'-Processing) inhibitor | 0.097 0.027 DBMET02092 0.107 0.023 DBMET02093 | DBMET02093 | |
| 0.013 | 0.025 | 0.047 | Retinoic acid receptor antagonist | 0.047 0.004 DBMET02092 0.031 0.005 DBMET02093 | DBMET02092 | |
| 0.015 | 0.028 | 0.059 | Retinoid X beta receptor agonist | 0.059 0.004 DBMET02092 0.028 0.009 DBMET02093 | DBMET02092 | |
| 0.078 | 0.092 | 0.21 | Monophenol monooxygenase inhibitor | 0.126 0.058 DBMET02091 0.142 0.05 DBMET02092 0.21 0.031 DBMET02093 | DBMET02093 | |
| 0.008 | 0.024 | 0.027 | Retinoic acid receptor gamma antagonist | 0.027 0.004 DBMET02092 0.017 0.005 DBMET02093 | DBMET02092 | |
| 0.12 | 0.137 | 0.192 | Dual specificity phosphatase inhibitor | 0.131 0.118 DBMET02091 0.192 0.059 DBMET02092 0.145 0.099 DBMET02093 | DBMET02092 | |
| 0.018 | 0.035 | 0.038 | Retinoic acid gamma receptor agonist | 0.038 0.004 DBMET02092 0.029 0.007 DBMET02093 | DBMET02092 | |
| 0.007 | 0.024 | 0.029 | Retinoic acid beta receptor antagonist | 0.029 0.004 DBMET02092 0.018 0.005 DBMET02093 | DBMET02092 | |
| 0.058 | 0.075 | 0.092 | Glutamate (mGluR6) antagonist | 0.062 0.059 DBMET02091 0.084 0.02 DBMET02092 0.092 0.014 DBMET02093 | DBMET02093 | |
| 0.019 | 0.039 | 0.026 | Vanilloid 2 agonist | 0.024 0.021 DBMET02092 0.026 0.017 DBMET02093 | DBMET02093 | |
| 0.081 | 0.101 | 0.197 | Protein-tyrosine phosphatase 1B inhibitor | 0.124 0.06 DBMET02091 0.197 0.03 DBMET02092 0.177 0.036 DBMET02093 | DBMET02092 | |
| 0.131 | 0.152 | 0.18 | Phospholipase C inhibitor | 0.166 0.078 DBMET02091 0.167 0.077 DBMET02092 0.18 0.06 DBMET02093 | DBMET02093 | |
| 0.016 | 0.039 | 0.062 | Retinoic acid receptor agonist | 0.062 0.005 DBMET02092 0.037 0.007 DBMET02093 | DBMET02092 | |
| 0.168 | 0.192 | 0.183 | Transcription factor STAT inhibitor | 0.183 0.164 DBMET02093 | DBMET02093 | |
| 0.149 | 0.174 | 0.19 | DNA damaging | 0.19 0.124 DBMET02091 | DBMET02091 | |
| 0.063 | 0.088 | 0.131 | Ornithine decarboxylase inhibitor | 0.094 0.051 DBMET02091 0.131 0.019 DBMET02092 0.11 0.034 DBMET02093 | DBMET02092 | |
| 0.064 | 0.091 | 0.11 | NMDA receptor antagonist | 0.11 0.041 DBMET02092 | DBMET02092 | |
| 0.058 | 0.09 | 0.068 | MDM2 inhibitor | 0.065 0.053 DBMET02091 0.068 0.044 DBMET02092 | DBMET02092 | |
| 0.141 | 0.175 | 0.273 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.155 0.137 DBMET02091 0.168 0.112 DBMET02092 0.273 0.033 DBMET02093 | DBMET02093 | |
| 0.013 | 0.048 | 0.039 | Retinoic acid beta receptor agonist | 0.039 0.004 DBMET02092 0.025 0.007 DBMET02093 | DBMET02092 | |
| 0.103 | 0.138 | 0.241 | Protein-tyrosine phosphatase inhibitor | 0.153 0.076 DBMET02091 0.241 0.033 DBMET02092 0.21 0.043 DBMET02093 | DBMET02092 | |
| 0.004 | 0.039 | 0.012 | Thromboxane agonist | 0.012 0.006 DBMET02093 | DBMET02093 | |
| 0.139 | 0.174 | 0.579 | Tumour necrosis factor alpha release inhibitor | 0.156 0.151 DBMET02091 0.579 0.008 DBMET02093 | DBMET02093 | |
| 0.07 | 0.105 | 0.16 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.06 DBMET02091 0.14 0.03 DBMET02092 0.16 0.024 DBMET02093 | DBMET02093 | |
| 0.016 | 0.057 | 0.033 | Nicotinic acid receptor 2 antagonist | 0.033 0.01 DBMET02092 | DBMET02092 | |
| 0.067 | 0.109 | 0.135 | Triose-phosphate isomerase inhibitor | 0.088 0.062 DBMET02091 0.115 0.035 DBMET02092 0.135 0.025 DBMET02093 | DBMET02093 | |
| 0.014 | 0.06 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DBMET02091 | DBMET02091 | |
| 0.146 | 0.194 | 0.238 | Superoxide dismutase inhibitor | 0.238 0.082 DBMET02092 0.227 0.091 DBMET02093 | DBMET02092 | |
| 0.025 | 0.074 | 0.077 | Retinoic acid alpha receptor agonist | 0.077 0.005 DBMET02092 0.061 0.009 DBMET02093 | DBMET02092 | |
| 0.023 | 0.074 | 0.038 | Glutamate (mGluR3) agonist | 0.036 0.014 DBMET02092 0.038 0.011 DBMET02093 | DBMET02093 | |
| 0.074 | 0.126 | 0.221 | AMP-activated protein kinase stimulant | 0.098 0.073 DBMET02091 0.136 0.037 DBMET02092 0.221 0.009 DBMET02093 | DBMET02093 | |
| 0.165 | 0.22 | 0.296 | Vasodilator, peripheral | 0.229 0.145 DBMET02091 0.235 0.14 DBMET02092 0.296 0.099 DBMET02093 | DBMET02093 | |
| 0.042 | 0.097 | 0.075 | NMDA receptor agonist | 0.075 0.032 DBMET02092 | DBMET02092 | |
| 0.015 | 0.072 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.018 DBMET02091 | DBMET02091 | |
| 0.062 | 0.12 | 0.084 | Prolactin inhibitor | 0.084 0.074 DBMET02091 | DBMET02091 | |
| 0.079 | 0.14 | 0.326 | Alpha-N-acetylglucosaminidase inhibitor | 0.133 0.067 DBMET02091 0.229 0.027 DBMET02092 0.326 0.014 DBMET02093 | DBMET02093 | |
| 0.066 | 0.126 | 0.154 | GABA C receptor agonist | 0.154 0.032 DBMET02092 0.109 0.058 DBMET02093 | DBMET02092 | |
| 0.175 | 0.237 | 0.411 | Histamine release inhibitor | 0.411 0.07 DBMET02092 0.349 0.1 DBMET02093 | DBMET02092 | |
| 0.038 | 0.103 | 0.081 | Antineoplastic antibiotic | 0.081 0.057 DBMET02093 | DBMET02093 | |
| 0.094 | 0.159 | 0.194 | Phospholipase A2 inhibitor | 0.194 0.046 DBMET02092 0.15 0.074 DBMET02093 | DBMET02092 | |
| 0.174 | 0.24 | 0.337 | Interleukin 2 agonist | 0.337 0.052 DBMET02091 0.241 0.129 DBMET02092 0.247 0.122 DBMET02093 | DBMET02091 | |
| 0.109 | 0.18 | 0.162 | Antipruritic | 0.162 0.081 DBMET02093 | DBMET02093 | |
| 0.077 | 0.151 | 0.122 | Cyclooxygenase 3 inhibitor | 0.122 0.075 DBMET02092 0.108 0.092 DBMET02093 | DBMET02092 | |
| 0.024 | 0.1 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.029 DBMET02092 | DBMET02092 | |
| 0.03 | 0.109 | 0.075 | Aconitate hydratase inhibitor | 0.075 0.016 DBMET02092 0.056 0.03 DBMET02093 | DBMET02092 | |
| 0.03 | 0.11 | 0.094 | Biliverdin reductase inhibitor | 0.08 0.026 DBMET02092 0.094 0.02 DBMET02093 | DBMET02093 | |
| 0.093 | 0.175 | 0.179 | Dual specificity phosphatase 3 inhibitor | 0.179 0.074 DBMET02092 0.127 0.12 DBMET02093 | DBMET02092 | |
| 0.037 | 0.119 | 0.058 | Sphingosine kinase inhibitor | 0.058 0.044 DBMET02091 | DBMET02091 | |
| 0.06 | 0.143 | 0.141 | Ferrochelatase inhibitor | 0.141 0.042 DBMET02092 | DBMET02092 | |
| 0.108 | 0.195 | 0.202 | Non-steroidal antiinflammatory agent | 0.144 0.123 DBMET02092 0.202 0.07 DBMET02093 | DBMET02093 | |
| 0.032 | 0.119 | 0.072 | Peroxisome proliferator-activated receptor gamma agonist | 0.072 0.047 DBMET02092 | DBMET02092 | |
| 0.061 | 0.149 | 0.091 | Thioredoxin inhibitor | 0.091 0.061 DBMET02093 | DBMET02093 | |
| 0.057 | 0.15 | 0.151 | UDP-glucose 4-epimerase inhibitor | 0.109 0.052 DBMET02092 0.151 0.028 DBMET02093 | DBMET02093 | |
| 0.024 | 0.126 | 0.078 | Argininosuccinate synthase inhibitor | 0.059 0.037 DBMET02092 0.078 0.026 DBMET02093 | DBMET02093 | |
| 0.068 | 0.175 | 0.1 | DOPA decarboxylase inhibitor | 0.1 0.075 DBMET02092 | DBMET02092 | |
| 0.059 | 0.166 | 0.141 | Adenylate cyclase inhibitor | 0.141 0.052 DBMET02093 | DBMET02093 | |
| 0.116 | 0.23 | 0.157 | Cyclic AMP phosphodiesterase inhibitor | 0.157 0.141 DBMET02092 | DBMET02092 | |
| 0.131 | 0.248 | 0.296 | DNA synthesis inhibitor | 0.196 0.129 DBMET02091 0.215 0.101 DBMET02092 0.296 0.045 DBMET02093 | DBMET02093 | |
| 0.099 | 0.216 | 0.21 | Interleukin agonist | 0.21 0.112 DBMET02091 0.208 0.113 DBMET02092 0.166 0.152 DBMET02093 | DBMET02091 | |
| 0.025 | 0.143 | 0.083 | Phosphofructokinase-1 inhibitor | 0.083 0.039 DBMET02093 | DBMET02093 | |
| 0.054 | 0.173 | 0.097 | Cystathionine beta-synthase inhibitor | 0.095 0.082 DBMET02092 0.097 0.08 DBMET02093 | DBMET02093 | |
| 0.04 | 0.159 | 0.077 | GABA aminotransferase inhibitor | 0.077 0.051 DBMET02092 0.069 0.063 DBMET02093 | DBMET02092 | |
| 0.031 | 0.15 | 0.099 | Porphobilinogen synthase inhibitor | 0.099 0.036 DBMET02092 | DBMET02092 | |
| 0.087 | 0.207 | 0.148 | Platelet adhesion inhibitor | 0.148 0.108 DBMET02093 | DBMET02093 | |
| 0.096 | 0.221 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.118 DBMET02092 | DBMET02092 | |
| 0.039 | 0.167 | 0.09 | Glutamate dehydrogenase inhibitor | 0.076 0.048 DBMET02092 0.09 0.036 DBMET02093 | DBMET02093 | |
| 0.028 | 0.156 | 0.049 | Heparanase inhibitor | 0.049 0.047 DBMET02092 | DBMET02092 | |
| 0.129 | 0.258 | 0.228 | Hypoxia-inducible factor 1 alpha inhibitor | 0.228 0.121 DBMET02093 | DBMET02093 | |
| 0.02 | 0.154 | 0.098 | Alcohol oxidase inhibitor | 0.067 0.031 DBMET02092 0.098 0.018 DBMET02093 | DBMET02093 | |
| 0.052 | 0.186 | 0.11 | NADH dehydrogenase inhibitor | 0.087 0.061 DBMET02092 0.11 0.035 DBMET02093 | DBMET02093 | |
| 0.023 | 0.157 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.034 DBMET02092 | DBMET02092 | |
| 0.137 | 0.273 | 0.371 | Antithrombotic | 0.218 0.156 DBMET02091 0.247 0.128 DBMET02092 0.371 0.057 DBMET02093 | DBMET02093 | |
| 0.046 | 0.185 | 0.092 | Creatine kinase inhibitor | 0.092 0.069 DBMET02093 | DBMET02093 | |
| 0.018 | 0.165 | 0.057 | Acyl-CoA dehydrogenase inhibitor | 0.057 0.036 DBMET02093 | DBMET02093 | |
| 0.059 | 0.206 | 0.173 | Thrombolytic | 0.117 0.114 DBMET02091 0.142 0.088 DBMET02092 0.173 0.066 DBMET02093 | DBMET02093 | |
| 0.043 | 0.193 | 0.118 | Expectorant | 0.118 0.052 DBMET02093 | DBMET02093 | |
| 0.081 | 0.233 | 0.221 | Growth hormone agonist | 0.221 0.051 DBMET02093 | DBMET02093 | |
| 0.061 | 0.214 | 0.127 | Adenylate kinase inhibitor | 0.103 0.063 DBMET02092 0.127 0.038 DBMET02093 | DBMET02093 | |
| 0.077 | 0.23 | 0.138 | Amyloid beta precursor protein antagonist | 0.138 0.116 DBMET02092 | DBMET02092 | |
| 0.007 | 0.169 | 0.031 | Prostaglandin agonist | 0.031 0.021 DBMET02093 | DBMET02093 | |
| 0.052 | 0.217 | 0.105 | Mucolytic | 0.105 0.07 DBMET02093 | DBMET02093 | |
| 0.045 | 0.21 | 0.101 | Chelator | 0.101 0.076 DBMET02092 | DBMET02092 | |
| 0.169 | 0.338 | 0.385 | Calcium channel L-type activator | 0.385 0.091 DBMET02091 0.297 0.16 DBMET02092 0.275 0.18 DBMET02093 | DBMET02091 | |
| 0.026 | 0.196 | 0.077 | Glutamate decarboxylase inhibitor | 0.077 0.047 DBMET02092 | DBMET02092 | |
| 0.047 | 0.245 | 0.093 | Electrolyte absorption antagonist | 0.093 0.069 DBMET02092 | DBMET02092 | |
| 0.096 | 0.294 | 0.258 | Hypoglycemic | 0.208 0.105 DBMET02091 0.196 0.116 DBMET02092 0.258 0.072 DBMET02093 | DBMET02093 | |
| 0.074 | 0.274 | 0.15 | P-glycoprotein inhibitor | 0.15 0.118 DBMET02093 | DBMET02093 | |
| 0.026 | 0.254 | 0.059 | Purinergic P2X1 antagonist | 0.059 0.045 DBMET02093 | DBMET02093 | |
| 0.067 | 0.297 | 0.119 | NOS3 expression enhancer | 0.119 0.117 DBMET02093 | DBMET02093 | |
| 0.026 | 0.256 | 0.052 | Factor III inhibitor | 0.052 0.03 DBMET02092 0.05 0.035 DBMET02093 | DBMET02092 | |
| 0.09 | 0.357 | 0.349 | Immunosuppressant | 0.349 0.087 DBMET02093 | DBMET02093 | |
| 0.026 | 0.372 | 0.06 | Adenine nucleotide translocase inhibitor | 0.057 0.035 DBMET02092 0.06 0.029 DBMET02093 | DBMET02093 | |
| 0.011 | 0.428 | 0.066 | Neuraminidase (influenza) inhibitor | 0.064 0.045 DBMET02092 0.066 0.041 DBMET02093 | DBMET02093 | |
| 0.084 | 0.522 | 0.292 | Cyclophilin D inhibitor | 0.284 0.178 DBMET02091 0.278 0.183 DBMET02092 0.292 0.17 DBMET02093 | DBMET02093 | |
| 0.038 | 0.499 | 0.632 | Interleukin 6 antagonist | 0.632 0.004 DBMET02093 | DBMET02093 | |
| 0.009 | 0.491 | 0.045 | Neuraminidase (Influenza A) inhibitor | 0.042 0.037 DBMET02092 0.045 0.032 DBMET02093 | DBMET02093 | |
| 0.022 | 0.644 | 0.41 | Interleukin 1b antagonist | 0.41 0.005 DBMET02093 | DBMET02093 | |
| 0.013 | 0.752 | 0.358 | Interleukin 1 antagonist | 0.358 0.008 DBMET02093 | DBMET02093 | |
| 0.016 | 0.756 | 0.194 | Angiogenesis inhibitor | 0.194 0.177 DBMET02093 | DBMET02093 | |
| 0.005 | 0.9 | 0.391 | Interleukin antagonist | 0.391 0.032 DBMET02093 | DBMET02093 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |